Research study Program year 2023 Source: CMS Open Payments

randomized & cetuximab vs afa alone

Research payments

$8,069,659

60 payments

Through program year 2023, $8,069,659 in research payments was reported against randomized & cetuximab vs afa alone, across 60 payments, paid by Boehringer Ingelheim Pharmaceuticals, Inc..

Paid by: Boehringer Ingelheim Pharmaceuticals, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$337,447	2
2022	Research	$660,600	4
2021	Research	$1,141,406	9
2020	Research	$2,548,262	17
2019	Research	$3,381,943	28

Breakdown

Who paid Research payments · program years 2019–2023

Boehringer Ingelheim Pharmaceuticals, Inc. $8,069,659 60 payments

Who received the money Research payments · program years 2019–2023

Smilow Cancer Hosp Yale New Haven Organisation paid for research $1,772,580 4 payments
Moores Ucsd Cancer Ctr Organisation paid for research $731,817 4 payments
Wichita Ncorp Pharm Organisation paid for research $461,445 2 payments
Ascension Via Christi Hospitals Wichita Inc Organisation paid for research $454,084 4 payments
Vidant Oncology Kinston Organisation paid for research $430,452 4 payments
Kaiser Permanente Woodland Hills Organisation paid for research $379,382 3 payments
Kaiser Permanente San Marcos Medical Offices Organisation paid for research $360,388 3 payments
St Lukes Medical Center Public Health Service Outpatient Organisation paid for research $295,548 2 payments
Karmanos Cancer Hospital Teaching hospital · MI $294,576 2 payments
The Jones Clinic Organisation paid for research $277,581 3 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

1 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

Sarah Goldberg New Haven, CT Named on 60 payments

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.